Clinicians' Attitudes toward General Screening of the Ashkenazi-Jewish Population for Prevalent Founder BRCA1/2 and LRRK2 Mutations. - Shkedi-Rafid, S.; Ofer-Bialer, G.; Meiner, V.; Calderon-Margalit, R. (Public Health Genomics, 2013)